TY - JOUR
T1 - Discrimination between Obesity and Insulin Resistance in the Relationship with Adiponectin
AU - Abbasi, Fahim
AU - Chu, James W.
AU - Lamendola, Cindy
AU - McLaughlin, Tracey
AU - Hayden, John
AU - Reaven, Gerald M.
AU - Reaven, Peter D.
PY - 2004/3
Y1 - 2004/3
N2 - Insulin resistance and obesity are both associated with lower plasma adiponectin concentrations. Since insulin resistance and obesity are related, the extent to which the association of adiponectin with insulin resistance is dependent on its relationship with obesity is unclear. To address this issue, fasting plasma adiponectin concentrations were measured in 60 nondiabetic subjects, stratified into four equal groups on the basis of both their degree of adiposity and insulin resistance. Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration in response to an infusion of octreotide, glucose, and insulin, and degree of adiposity was assessed by BMI. Subjects were defined as obese (BMI ≥ 30.0 kg/m 2) or nonobese (< 27.0 kg/m2) and as either insulin sensitive (SSPG < 100 mg/dl) or insulin resistant (> 190 mg/dl). Insulin-resistant subjects had significantly (P < 0.001) lower (mean ± SD) adiponectin concentrations, whether they were obese (17.1 ± 5.9 μg/ml) or nonobese (16.3 ± 7.5 μg/ml) as compared with either obese, insulin-sensitive (34.3 ± 13.1 μg/ml) or nonobese, insulin-sensitive (29.8 ± 15.3 μ/ml) subjects. Finally, adiponectin levels in insulin-sensitive subjects varied to a significantly greater degree than in insulin-resistant subjects. These results suggest that adiponectin concentrations are more closely related to differences in insulin-mediated glucose disposal than obesity.
AB - Insulin resistance and obesity are both associated with lower plasma adiponectin concentrations. Since insulin resistance and obesity are related, the extent to which the association of adiponectin with insulin resistance is dependent on its relationship with obesity is unclear. To address this issue, fasting plasma adiponectin concentrations were measured in 60 nondiabetic subjects, stratified into four equal groups on the basis of both their degree of adiposity and insulin resistance. Insulin resistance was quantified by determining the steady-state plasma glucose (SSPG) concentration in response to an infusion of octreotide, glucose, and insulin, and degree of adiposity was assessed by BMI. Subjects were defined as obese (BMI ≥ 30.0 kg/m 2) or nonobese (< 27.0 kg/m2) and as either insulin sensitive (SSPG < 100 mg/dl) or insulin resistant (> 190 mg/dl). Insulin-resistant subjects had significantly (P < 0.001) lower (mean ± SD) adiponectin concentrations, whether they were obese (17.1 ± 5.9 μg/ml) or nonobese (16.3 ± 7.5 μg/ml) as compared with either obese, insulin-sensitive (34.3 ± 13.1 μg/ml) or nonobese, insulin-sensitive (29.8 ± 15.3 μ/ml) subjects. Finally, adiponectin levels in insulin-sensitive subjects varied to a significantly greater degree than in insulin-resistant subjects. These results suggest that adiponectin concentrations are more closely related to differences in insulin-mediated glucose disposal than obesity.
UR - http://www.scopus.com/inward/record.url?scp=1442326009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1442326009&partnerID=8YFLogxK
U2 - 10.2337/diabetes.53.3.585
DO - 10.2337/diabetes.53.3.585
M3 - Article
C2 - 14988241
AN - SCOPUS:1442326009
SN - 0012-1797
VL - 53
SP - 585
EP - 590
JO - Diabetes
JF - Diabetes
IS - 3
ER -